EBT-101

BIOLOGICAL2 trials

Sponsors

Excision BioTherapeutics

Conditions

HIV-1-infection

Phase 1

Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

Enrolling by invitationNCT05143307

Excision BioTherapeuticsHIV-1-infection

Start: 2023-07-11End: 2037-04-30Target: 9Updated: 2024-05-14

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

CompletedNCT05144386

Excision BioTherapeuticsHIV-1-infection

Start: 2022-01-24End: 2024-11-14Updated: 2024-12-02